Efficacy and Safety Study of Trastuzumab and Paclitaxel Based Regimens to Treat HER2-positive Breast Cancer

Clinical trial NCT01428414 · UNKNOWN

Trial details

NCT number: NCT01428414
Sponsor: Zhimin Shao
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

HER-2 Positive Breast Cancer

Start date: 2011-08-01
Primary completion: 2014-08-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.